SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-21-000510
Filing Date
2021-09-13
Accepted
2021-09-13 17:12:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 fortebiosciences13g.htm SC 13G 57585
  Complete submission text file 0000935836-21-000510.txt   59219
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89959 | Film No.: 211250429
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129 4158014660
Logos Global Management LP (Filed by) CIK: 0001792126 (see all company filings)

IRS No.: 833997742 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G